ScienceEU-Startupsabout 1 hour ago
Pixelgen secures €13.26M for cell-surface protein mapping
3 min read
Pixelgen Technologies closed an oversubscribed €13.26 million ($15.5 million) Series B round led by new investor Flat Capital, with existing investors Industrifonden and Navigare Ventures participating. The Stockholm life sciences company develops a high-throughput platform for mapping molecular cell architecture. Flat Capital CEO Rickard El Tarzi and Ramon Felciano, Ph.D., joined the board.
Level
Hype check
Tap to vote and see what everyone thinks.
In this storyMicrosoft
Summary by ByteBrief
